Talking Rheumatology Research
Discover the latest research from Rheumatology, Rheumatology Advances in Practice, and beyond.
Talking Rheumatology Research
Ep 25. How does symptom duration before DMARD therapy impact the costs of RA?
•
British Society for Rheumatology
•
Episode 25
Dr Ilfita Sahbudin (University of Birmingham, UK) joins Dr Ai Lyn Tan to discuss the relationship between symptom/disease duration and resource utilisation/costs following rheumatoid arthritis diagnosis.
Want to read the full paper? Find it here.
Thanks for listening to Talking Rheumatology Research! Join the conversation on X using #TalkingRheumResearch, tweet us @RheumJnl, or find us on Instagram and LinkedIn.
Want to read more rheumatology research? Explore Rheumatology and Rheumatology Advances in Practice.